StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2024, quý kết thúc ngày Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Vaccinex's ebitda for the twelve months ending Dec 31, 2019 was -$31.77M. For fiscal 2019 it was -$31.77M.

Annual ebitda

PeriodPeriod endValueChange
FY2019Dec 31, 2019-$31.77M–
FY2018Dec 31, 2018-$27.06M–
FY2017Dec 31, 2017-$20.90M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019-$6.27M–
Q3 FY2019Sep 30, 2019-$7.61M–
Q2 FY2019Jun 30, 2019-$8.80M–
Q1 FY2019Mar 31, 2019-$9.08M–
Q4 FY2018Dec 31, 2018-$8.50M–
Q3 FY2018Sep 30, 2018-$6.40M–
Q2 FY2018Jun 30, 2018-$6.50M-114.3%
Q1 FY2018Mar 31, 2018-$5.65M–
Q4 FY2017Dec 31, 2017-$6.14M–
Q3 FY2017Sep 30, 2017-$5.28M–
Q2 FY2017Jun 30, 2017$45.33M–

More Vaccinex figures

See a number that looks wrong?